{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:28:15Z","timestamp":1786987695754,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.diabres.2024.111609","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T12:22:40Z","timestamp":1710159760000},"page":"111609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The hidden epidemic: Uncovering incidental fatty liver disease and its metabolic comorbidities by datamining in a hospital data lake \u2013 A real-world cohort study"],"prefix":"10.1016","volume":"210","author":[{"given":"Iiro P.","family":"Karhiaho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samu H.","family":"Kurki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helka I.","family":"Parviainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liisa","family":"Kullamaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martti A.","family":"F\u00e4rkkil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niina","family":"Matikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiinamaija","family":"Tuomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2024.111609_b0005","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2024.111609_b0010","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"The Lancet"},{"key":"10.1016\/j.diabres.2024.111609_b0015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2024.111609_b0020","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.diabres.2024.111609_b0025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12916-018-1103-x","article-title":"Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease","volume":"16","author":"Alexander","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.diabres.2024.111609_b0030","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/j.gastro.2019.09.008","article-title":"Ability of noninvasive scoring systems to identify individuals in the population at risk for severe liver disease","volume":"158","author":"Hagstr\u00f6m","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.diabres.2024.111609_b0035","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.diabres.2024.111609_b0040","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL\u2013EASD\u2013EASO. Clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2024.111609_b0045","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1111\/j.1572-0241.2007.01520.x","article-title":"Abdominal ultrasound for diagnosis of nonalcoholic fatty liver disease (NAFLD)","volume":"102","author":"Mishra","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.diabres.2024.111609_b0050","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.diabres.2024.111609_b0055","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1148\/radiol.2391050361","article-title":"Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment","volume":"239","author":"Park","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.diabres.2024.111609_b0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/cld.538","article-title":"Noninvasive evaluation of nonalcoholic fatty liver disease","volume":"7","author":"Renelus","year":"2016","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.diabres.2024.111609_b0065","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S2468-1253(23)00017-1","article-title":"Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study","volume":"8","author":"Vali","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2024.111609_b0070","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jhep.2022.02.021","article-title":"et a. Development and validation of a model to predict incident chronic liver disease in the general population: The CLivD score","volume":"77","author":"\u00c5berg","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2024.111609_b0075","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.diabres.2024.111609_b0080","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1665-2681(19)31317-1","article-title":"Primary care practitioners survey of non-alcoholic fatty liver disease","volume":"12","author":"Said","year":"2013","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.diabres.2024.111609_b0085","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10620-014-3346-5","article-title":"Gaps in recognition and evaluation of incidentally identified hepatic steatosis","volume":"60","author":"Wright","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.diabres.2024.111609_b0090","first-page":"641","article-title":"Tagging incidental finding of fatty liver on ultrasound: a novel intervention to improve early detection of liver fibrosis","volume":"7","author":"Nagra","year":"2021","journal-title":"J Clin Transl Res"},{"key":"10.1016\/j.diabres.2024.111609_b0095","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.diabres.2024.111609_b0100","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","author":"American Diabetes Association","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2024.111609_b0105","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.cgh.2019.08.007","article-title":"Identification and characterization of nonalcoholic fatty liver disease","volume":"18","author":"Goldshtein","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2024.111609_b0110","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrgastro.2013.149","article-title":"From NAFLD to NASH to cirrhosis\u2014new insights into disease mechanisms","volume":"10","author":"Wree","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2024.111609_b0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/endocr\/bqaa134","article-title":"NAFLD and NASH in postmenopausal women: implications for diagnosis and treatment","volume":"161","author":"DiStefano","year":"2020","journal-title":"Endocrinology"},{"key":"10.1016\/j.diabres.2024.111609_b0120","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2337\/db18-0638","article-title":"Estrogen improves insulin sensitivity and suppresses gluconeogenesis via the transcription factor Foxo1","volume":"68","author":"Yan","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2024.111609_b0125","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1210\/jc.2015-1966","article-title":"High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and Normal plasma aminotransferase levels","volume":"100","author":"Portillo-Sanchez","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2024.111609_b0130","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1210\/jc.2007-0482","article-title":"Liver fat in the metabolic syndrome","volume":"92","author":"Kotronen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2024.111609_b0135","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/apt.12923","article-title":"Nonalcoholic fatty liver disease (NAFLD) in the veterans administration population: development and validation of an algorithm for NAFLD using automated data","volume":"40","author":"Husain","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.diabres.2024.111609_b0140","doi-asserted-by":"crossref","unstructured":"Serper M, Vujkovic M, Kaplan DE, et al. Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program. Palmer ND, ed. PLoS One 2020; 15: e0237430.","DOI":"10.1371\/journal.pone.0237430"},{"key":"10.1016\/j.diabres.2024.111609_b0145","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/liv.14828","article-title":"Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population","volume":"41","author":"Ciardullo","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.diabres.2024.111609_b0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12876-022-02290-1","article-title":"Distribution of FIB-4 index in the general population: analysis of 75,666 residents who underwent health checkups","volume":"22","author":"Sugiyama","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.diabres.2024.111609_b0155","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s10620-019-05986-9","article-title":"Impact of NAFLD on the incidence of cardiovascular diseases in a primary care population in Germany","volume":"65","author":"Labenz","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.diabres.2024.111609_b0160","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: a clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.diabres.2024.111609_b0165","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1172\/JCI30400","article-title":"Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease","volume":"117","author":"Samuel","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2024.111609_b0170","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1053\/j.gastro.2012.03.003","article-title":"Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects","volume":"142","author":"Magkos","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.diabres.2024.111609_b0175","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2024.111609_b0180","doi-asserted-by":"crossref","unstructured":"Alves\u2010Bezerra M, Cohen DE. Triglyceride Metabolism in the Liver. In: Comprehensive Physiology.Vol 8. Wiley, 2017, 1\u201322.","DOI":"10.1002\/cphy.c170012"},{"key":"10.1016\/j.diabres.2024.111609_b0185","first-page":"2499","article-title":"The Emerging Risk Factors Collaboration. Lipid-Related Markers and Cardiovascular Disease Prediction","volume":"307","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2024.111609_b0190","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies\u2014a consensus statement from the European atherosclerosis society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2024.111609_b0195","first-page":"220","article-title":"Define metabolite profiles during a glucose tolerance test in young adult twins","volume":"102","author":"R\u00e4m\u00f6","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2024.111609_b0200","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.26156","article-title":"Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States","volume":"57","author":"Kim","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.diabres.2024.111609_b0205","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2337\/dc20-1778","article-title":"High prevalence of advanced liver fibrosis assessed by transient elastography among U.S. adults with type 2 diabetes","volume":"44","author":"Ciardullo","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2024.111609_b0210","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2337\/dc20-1997","article-title":"Advanced liver fibrosis is common in patients with type 2 diabetes followed in the outpatient setting: the need for systematic screening","volume":"44","author":"Lomonaco","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2024.111609_b0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL\u2013Lancet liver commission: protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2024.111609_b0220","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s10620-016-4044-2","article-title":"Screening for nonalcoholic steatohepatitis in individuals with type 2 diabetes: a cost-effectiveness analysis","volume":"61","author":"Corey","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.diabres.2024.111609_b0225","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1007\/s10620-017-4721-9","article-title":"Accurate identification of fatty liver disease in data warehouse utilizing natural language processing","volume":"62","author":"Redman","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.diabres.2024.111609_b0230","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","article-title":"Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study","volume":"51","author":"Dasarathy","year":"2009","journal-title":"J Hepatol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822724000937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822724000937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T01:43:58Z","timestamp":1731375838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822724000937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":46,"alternative-id":["S0168822724000937"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2024.111609","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The hidden epidemic: Uncovering incidental fatty liver disease and its metabolic comorbidities by datamining in a hospital data lake \u2013 A real-world cohort study","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2024.111609","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111609"}}